CK2
CK2(酪蛋白激酶 2)
CK2 is a serine/threonine-selective protein kinase that has been implicated in cell cycle control, DNA repair, regulation of the circadian rhythm and other cellular processes.
CK2 相关产品(9)
- GC13037CX-4945 (Silmitasertib)CAS: 1009820-21-6纯度: >99.50%
CX-4945 (Silmitasertib)是一种有效的具口服活性的酪蛋白激酶2（CK2）抑制剂，对CK2α的IC 50 值为1nM。
- GC50009LY 294002 hydrochlorideCAS: 934389-88-5纯度: >98.00%
Prototypical PI 3-kinase inhibitor; also inhibits other kinases
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC10649 | TTP 22 | 329907-28-0 | >98.00% | |
A CK2 inhibitor | ||||
| GC12181 | TBB | 17374-26-4 | >99.00% / >99.50% / >98.00% | |
TBB是一种细胞可渗透的ATP竞争性CK2抑制剂，对大鼠肝脏CK2的IC 50 为0.15μM。 | ||||
| GC17837 | DMAT | 749234-11-5 | >98.00% | |
A cell-permeable inhibitor of CK2 | ||||
| GC11325 | CX-4945 sodium salt | 1309357-15-0 | >99.50% | |
A potent, orally bioavailable CK2 inhibitor | ||||
| GC11907 | NSC 210902 | 51726-83-1 | - | |
A selective CK2 inhibitor | ||||
| GC13037 | CX-4945 (Silmitasertib) | 1009820-21-6 | >99.50% | |
CX-4945 (Silmitasertib)是一种有效的具口服活性的酪蛋白激酶2（CK2）抑制剂，对CK2α的IC 50 值为1nM。 | ||||
| GC14181 | TBCA | 934358-00-6 | >99.50% | |
An inhibitor of casein kinase 2 | ||||
| GC16960 | 4,5,6,7-Tetrabromobenzimidazole | 577779-57-8 | - | |
A selective inhibitor of CK2 | ||||
| GC50009 | LY 294002 hydrochloride | 934389-88-5 | >98.00% | |
Prototypical PI 3-kinase inhibitor; also inhibits other kinases | ||||